Skip to content

A New and Innovative Method for CO2 Removal in Anesthetic Circuits: Replacing Chemical Granulate

Anesthesia

The drawbacks of chemical CO2 absorbers include the production of compounds harmful to patients that also lead into increased cost and environmental impact, as well as the daily disposal of compound special waste. Sustainable management of general anesthesia is a growing concern. Continually diluting anesthetic circuits, and the disposal of chemical granulate are serious environmental problems.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* American Society of Anesthesiologists Physical Status Class I, II, III (low-medium risk patient)
* English-speaking patients

Exclusion Criteria:

* Self-reported as pregnant
* American Society of Anesthesiologists Physical Status Class IV (high risk patient)
* Patients scheduled for emergency surgery
* Documented respiratory disease, including COPD and severe asthma
* Documented elevated pressure in the brain (intra cranial pressure, ICP)

Study Location

McGill University Health Centre
McGill University Health Centre
Montréal, Quebec
Canada

Contact Study Team

Queen Elizabeth II HSC, Halifax Infirmary Site
Queen Elizabeth II HSC, Halifax Infirmary Site
Halifax, Nova Scotia
Canada

Contact Study Team

Primary Contact

Orlando Hung, MD

[email protected]
(902)473-7736
Study Sponsored By
DMF Medical Incorporated
Participants Required
More Information
Study ID: NCT03014336